Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 2, 2012, to file lead plaintiff applications in a securities class action lawsuit against Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX), if they purchased the Company’s common stock during the period between November 9, 2010, and April 26, 2012, inclusive (the "Class Period"). This action is pending in the U. S. District Court for the Northern District of Illinois.
What You May Do
If you purchased shares of Allscripts Healthcare and would like to discuss your legal rights and how this case might affect your right to recover for your economic loss, you may, without obligation or cost to you, e-mail or call KSF Managing Partner, Lewis Kahn (email@example.com), toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or KSF Director of Client Relations, Neil Rothstein, Esq. (firstname.lastname@example.org), toll free at 877-694-9510, or via cell phone any time at 330-860-4092. If you wish to serve as lead plaintiff in this class action, you must petition the Court by July 2, 2012.
About the Lawsuit
Allscripts and certain of its senior executives are charged with issuing materially false and misleading statements, during the Class Period, in violation of federal securities laws.
On April 27, 2012, shares of Allscripts fell $5.72, to close at $10.30, after the Company announced operating results for 1Q:12, that were sharply below guidance. At that time, investors first learned of the problems that had been adversely impacting the Company throughout the Class Period. At that time, the Company also disclosed the termination of its Board Chairman; the resignation of three directors; and the resignation of Allscripts’ Chief Financial Officer.
About Kahn Swick & Foti, LLC
To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.